Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Horizon Pharma PLC (NASDAQ:HZNP)

13.86
Delayed Data
As of Oct 23
 -0.23 / -1.63%
Today’s Change
9.45
Today|||52-Week Range
21.98
-14.34%
Year-to-Date
No recent news for Horizon Pharma PLC.

Today’s Trading

Previous close14.09
Today’s open14.10
Day’s range13.71 - 14.10
Volume1,239,291
Average volume (3 months)3,540,622
Market cap$2.3B
Dividend yield--
Data as of 10/23/2017

Growth & Valuation

Earnings growth (last year)-516.00%
Earnings growth (this year)-50.27%
Earnings growth (next 5 years)+16.50%
Revenue growth (last year)+38.18%
P/E ratioNM
Price/Sales2.49
Price/Book1.80

Competitors

 Today’s
change
Today’s
% change
AXONAxovant Sciences Ltd-0.17-2.99%
PRTAProthena Corporation...+0.04+0.07%
SUPNSupernus Pharmaceuti...-0.45-1.08%
FOLDAmicus Therapeutics ...-0.32-2.35%
Data as of 10/23/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)$0.22
Annual revenue (last year)$1.0B
Annual profit (last year)-$166.8M
Net profit margin-15.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Timothy P. Walbert
Chief Financial Officer &
Executive Vice President
Paul W. Hoelscher
Corporate headquarters
Dublin, Dublin

Forecasts